These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38918301)

  • 21. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.
    Kang KA; Lee SR; Jun DW; Do IG; Kim MS
    Med Ultrason; 2023 Mar; 25(1):7-13. PubMed ID: 36780603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Fat Quantification With Novel Ultrasound Based Techniques: A Diagnostic Performance Study Using Magnetic Resonance Imaging Proton Density Fat Fraction as Reference Standard.
    Şendur HN; Özdemir Kalkan D; Cerit MN; Kalkan G; Şendur AB; Özhan Oktar S
    Can Assoc Radiol J; 2023 May; 74(2):362-369. PubMed ID: 36113064
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrasound attenuation imaging: a reproducible alternative for the noninvasive quantitative assessment of hepatic steatosis in children.
    Dardanelli EP; Orozco ME; Oliva V; Lutereau JF; Ferrari FA; Bravo MG; Ruvinsky S; Roel M; Barvosa PC; Armeno M; Kaplan JS
    Pediatr Radiol; 2023 Jul; 53(8):1618-1628. PubMed ID: 36869263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
    Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
    BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of T2 relaxation time for hepatic iron grading in rat model of fatty and fibrotic liver.
    Jin M; Jiang Y; Zhao Q; Pan Z; Xiao F
    PLoS One; 2022; 17(12):e0278574. PubMed ID: 36469532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth.
    Ferraioli G; De Silvestri A; Torres G; Barr RG
    Abdom Radiol (NY); 2024 Aug; 49(8):2622-2628. PubMed ID: 38834778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked difference in liver fat measured by histology
    Qadri S; Vartiainen E; Lahelma M; Porthan K; Tang A; Idilman IS; Runge JH; Juuti A; Penttilä AK; Dabek J; Lehtimäki TE; Seppänen W; Arola J; Arkkila P; Stoker J; Karcaaltincaba M; Pavlides M; Loomba R; Sirlin CB; Tukiainen T; Yki-Järvinen H
    JHEP Rep; 2024 Jan; 6(1):100928. PubMed ID: 38089550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
    Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
    J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
    Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
    J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.
    Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB;
    Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients.
    Siddiqui MS; Idowu MO; Stromberg K; Sima A; Lee E; Patel S; Ghaus S; Driscoll C; Sterling RK; John B; Bhati CS
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):367-374. PubMed ID: 32272251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
    Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
    JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging.
    Rehman A; Darira J; Hamid K; Ahmed MS; Shazlee MK; Amirali A
    Cureus; 2022 Mar; 14(3):e23435. PubMed ID: 35494925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.
    Tada T; Kumada T; Toyoda H; Nakamura S; Shibata Y; Yasuda S; Watanuki Y; Tsujii K; Fukuda N; Fujioka M; Takeshima K; Niwa F; Ogawa S; Hashinokuchi S; Kataoka S; Ichikawa H; Iijima H
    Hepatol Res; 2020 Dec; 50(12):1319-1327. PubMed ID: 32876367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease.
    Zhu SH; Zheng KI; Hu DS; Gao F; Rios RS; Li G; Li YY; Byrne CD; Targher G; Chen YP; Zheng MH
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):430-435. PubMed ID: 32398489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
    Runge JH; van Giessen J; Draijer LG; Deurloo EE; Smets AMJB; Benninga MA; Koot BGP; Stoker J
    Eur Radiol; 2021 Mar; 31(3):1588-1596. PubMed ID: 32910234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.